US approves Fresenius purchase of NxStage with conditions
WASHINGTON, Feb 19 (Reuters) - The U.S. Federal Trade Commission has given Fresenius Medical Care AG and NxStage Medical Inc antitrust approval for their merger with conditions, the agency said on Tuesday. (Reporting by Diane Bartz Editing by James Dalgleish)